Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited)

v3.24.2.u1
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 4,976 $ 6,071
Short-term investments 6,741 17,859
Income taxes receivable 178 38
Prepaid expenses and other current assets 1,800 1,628
Total current assets 13,695 25,596
Property and equipment, net 38 51
Restricted cash 34 34
Other assets 407 578
Total assets 14,174 26,259
Current liabilities:    
Accounts payable 822 4,996
Accrued expenses 2,260 7,761
Exchangeable Notes 12,952  
Other current liabilities 741 761
Total current liabilities 16,775 13,518
Exchangeable Notes   11,453
Royalty-linked notes 8,296 7,503
Other liabilities 16 188
Total liabilities 25,087 32,662
Commitments and contingencies (Note 14)
Shareholders' deficit    
Undesignated preferred shares, $0.01 par value per share: 100,000,000 shares authorized at June 30, 2024 and December 31, 2023; no shares issued at June 30, 2024 and December 31, 2023
Ordinary shares, $0.01 par value per share: 80,000,000 shares authorized at June 30, 2024 and December 31, 2023, 16,584,029 shares issued at June 30, 2024; 13,499,003 shares issued at December 31, 2023 166 135
Additional paid-in capital 462,318 454,759
Accumulated deficit (473,396) (461,298)
Accumulated other comprehensive (loss) / income (1) 1
Total shareholders' deficit (10,913) (6,403)
Total liabilities and shareholders' deficit $ 14,174 $ 26,259